Topics in Drug Testing from Quest Diagnostics
Health & Fitness
Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include:
The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division.
----more----
You may download a PDF version of this presentation here >>
To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
Medication adherence testing
Limitations of point-of-care testing
Phosphatidylethanol (PEth) blood test - Now available from Quest Diagnostics
The CDC Clinical Practice Guideline for Prescribing Opioids for Pain
Ketamine: a re-emergence in medicine and misuse?
Windows of Detection
Contributing Factors to the Skyrocketing Drug Misuse Epidemic in the US
Fentanyl: A substance of great concern
Presumptive vs definitive drug testing: what you need to know
Special Episode: Trends in drug testing resulting from the COVID-19 pandemic
Pharmacogenomics in mental health and addiction
Implementing a Drug Monitoring Protocol in your practice
Alternative Specimen Collection Options
The epidemic within the pandemic
Drug testing for stimulants
Drug Misuse in America
Kratom: Identifying ”a drug of concern”
Why and when to use oral fluid testing
Dangerous drug combinations
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Your Sleep Guru Podcast
Good Nurse Bad Nurse
Nothing much happens: bedtime stories to help you sleep
این نقطه